WebCytoMed Therapeutics Pte. Ltd. operates as a pre-clinical biopharmaceutical company. The Company focuses on developing novel cell-based immunotherapies for treatment of … WebCytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the …
CytoMed Therapeutics Pte Ltd - Startup SG
WebCytoMed Therapeutics Pte. Ltd. (Exact Name of Registrant as Specified in its Charter) Not Applicable (Translation of Registrant’s Name into English) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation Rule Amount to be Registered Proposed Maximum Offering Price Per Unit Proposed WebNov 29, 2024 · IPO Update: CytoMed Therapeutics Aims For $11 Million U.S. IPO Donovan Jones Fri, Feb. 03 CytoMed Therapeutics Begins U.S. IPO Effort Donovan Jones Tue, Nov. 29, 2024 Share your Analysis on... ray\\u0027s chimney colorado springs
CytoMed Therapeutics - Overview, News & Competitors
WebSep 21, 2024 · CytoMed Therapeutics Pte Ltd Study record dates These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public … WebNov 29, 2024 · A high-level overview of CytoMed Therapeutics Pte. Ltd. (GDTC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading … WebOn January 19, 2024, the registrant converted from a private company limited by shares incorporated in Singapore, known as CytoMed Therapeutics Pte. Ltd. to a public company limited by shares pursuant to the provisions of the Singapore Companies Act. simply racing